WEBULL
News
EBS
11.03
+1.01%
0.11
Weekly Report: what happened at EBS last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at EBS last week (0126-0130)?
Weekly Report · 02/02 09:56
Weekly Report: what happened at EBS last week (0119-0123)?
Weekly Report · 01/26 09:56
Weekly Report: what happened at EBS last week (0112-0116)?
Weekly Report · 01/19 10:00
Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading
Benzinga · 01/16 12:46
Emergent BioSolutions Shares Fall On Settlement With N.Y. Attorney General
Dow Jones · 01/15 20:55
N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading
Dow Jones · 01/15 17:34
Former Emergent BioSolutions CEO sued by NY AG for insider trading
TipRanks · 01/15 16:50
Emergent BioSolutions outlines transformation and financial guidance at conference
TipRanks · 01/14 22:28
Emergent BioSolutions: FDA Approves SNDA For NARCAN Carrying Case
NASDAQ · 01/14 13:33
Emergent announces U.S. FDA approved sNDA for OTC NARCAN nasal spray
TipRanks · 01/14 13:05
Investors five-year losses continue as Emergent BioSolutions (NYSE:EBS) dips a further 7.5% this week, earnings continue to decline
Simply Wall St · 01/14 10:42
Emergent BioSolutions Advances Turnaround With Major Debt Prepayment
TipRanks · 01/12 13:50
Emergent BioSolutions Made Voluntary Prepayment Of $100M Under Its Outstanding Term Loan Facility In Late December 2025, Using Cash On Hand
Benzinga · 01/12 12:48
Emergent BioSolutions announces $100M paydown of term loan principal
TipRanks · 01/12 12:47
Press Release: Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
Dow Jones · 01/12 12:30
Weekly Report: what happened at EBS last week (0105-0109)?
Weekly Report · 01/12 09:59
Emergent BioSolutions Gets $21.5M Anthrax Vaccination Order From Pentagon
Dow Jones · 01/08 22:10
Emergent BioSolutions receives $21.5M BioThrax order from Department of War
TipRanks · 01/08 21:45
Emergent BioSolutions Bags Delivery Order Valued At Up To $21.5M From U.S. Department Of War To Supply BioThrax In 2026
Benzinga · 01/08 21:32
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.